Clinical Trials Sponsored by SN BioScience

Total 1866 results

YM BioSciences

Terminated

DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer

Breast Cancer | Metastases

United Kingdom
Lumen Bioscience, Inc.

Not yet recruiting

Etiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia (AusTD)

Travelers Diarrhea
Txinno Bioscience Inc.

Recruiting

A Study of TXN10128 in Subjects With Solid Tumors

Locally Advanced (Unresectable) or Metastatic Solid Tumors

Korea, Republic of
Aadi Bioscience, Inc.

Recruiting

Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment

Advanced Solid Tumor | Tumor | Tumor, Solid

United States
Intima Bioscience, Inc.

Not yet recruiting

CISH Inactivated TILs in the Treatment of NSCLC (CheckCell-2)

Carcinoma, Non-Small-Cell Lung | Adenocarcinoma of Lung | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Metastatic Non Small Cell Lung Cancer | Large Cell Lung Cancer

United States
Trellis Bioscience LLC

Not yet recruiting

Study to Evaluate Safety and Activity of TRL1068 in Chronic Rhinosinusitis

Chronic Rhinosinusitis With Nasal Polyps
Cothera Bioscience, Inc

Recruiting

Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma

Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphatic Diseases | Burkitt Lymphoma | High-grade B-cell Lymphoma | C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma | C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma | Lymphoma, High-Grade | C-Myc Gene Rearrangement

Korea, Republic of, China
Aadi Bioscience, Inc.

Recruiting

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

Malignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic Neoplasm

Korea, Republic of, United States, Puerto Rico
SinoMab BioScience Ltd

Recruiting

A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX

Rheumatoid Arthritis(RA)

China
Blaze Bioscience Inc.

Available

Expanded Access for BLZ-100 (Tozuleristide)
Skye Bioscience, Inc.

Completed

Phase 2, Placebo-Controlled, Study Assessing the Safety and Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Patients With Elevated Eye Pressure

Primary Open Angle Glaucoma | Ocular Hypertension

United States
Aadi Bioscience, Inc.

Completed

Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer

Colorectal Cancer Metastatic

United States
Daré Bioscience, Inc.

Completed

Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA (DARE-VVA1)

Vulvar Atrophy

Australia
Alligator Bioscience AB

Completed

Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017

Neoplasms | Solid Tumor

Sweden
Meridian Bioscience, Inc.

Completed

BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis (MBT)

Chronic Liver Disease

United States, Israel
Meridian Bioscience, Inc.

Completed

BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH

Non-Alcoholic Steatohepatitis

United States, France, Belgium, United Kingdom
Meridian Bioscience, Inc.

Completed

Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis

Hepatocellular Carcinoma (HCC)

China
Meridian Bioscience, Inc.

Completed

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Chronic Liver Disease

United States, Israel
Meridian Bioscience, Inc.

Completed

Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

Helicobacter Pylori Infection

United States, Israel
Meridian Bioscience, Inc.

Completed

Show Equivalence of the Modified BreathID Compared to Currently Approved BreathID in H.Pylori Detection

Suspicion of Being Infected With H.Pylori

United States
Meridian Bioscience, Inc.

Completed

Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics

Helicobacter Pylori Infection

United States, Israel
Daré Bioscience, Inc.

Completed

DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)

Bacterial Vaginosis

United States
Alligator Bioscience AB

Completed

Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015

Neoplasms | Solid Tumor

Denmark, Sweden
Daré Bioscience, Inc.

Completed

Pharmacokinetic Study of DARE-BV1

Bacterial Vaginosis

United States
Lumen Bioscience, Inc.

Completed

Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies

C. Diff. Infections

Australia
INVO Bioscience, Inc.

Active, not recruiting

3 Year Retrospective Analysis of IVF in Comparison With INVOcell

Infertility

United States
Themis Bioscience GmbH

Completed

Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001) (MV-ZIKA-RSP)

Zika Virus Infection

Austria
SinoMab BioScience Ltd

Completed

A Study of the Pharmacokinetics and Safety of SM03 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Quadram Institute Bioscience

Completed

Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status

Hyperlipidemia

United Kingdom
ICON Bioscience Inc

Terminated

Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery

Inflammatory Reaction Due to Ocular Lens Prosthesis

United States
ICON Bioscience Inc

Completed

Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery

Cataract

United States
ICON Bioscience Inc

Completed

The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery

Inflammation | Cataracts

United States
Blaze Bioscience Inc.

Completed

Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery

Tumors, Breast

United States
Alligator Bioscience AB

Completed

ADC-1013 First-in-Human Study

Neoplasms | Solid Tumors

United Kingdom, Denmark, Sweden
Biofrontera Bioscience GmbH

Completed

A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis

Actinic Keratosis
Perle Bioscience, Inc.

Withdrawn

The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes (IIT)

Type 1 Diabetes
Meridian Bioscience, Inc.

Completed

Detection of Mycoplasma Pneumoniae

Mycoplasma Pneumoniae

United States
Ashley Downs Bioscience

Unknown

ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial

Nausea | Vomiting | Diarrhea | Oral Mucositis

United States
Tethys Bioscience, Inc.

Unknown

Prospective Observational Study Assessing Treatment and Outcomes of Patients With Prediabetes

Prediabetes
Ardana Bioscience Ltd

Completed

Open-Label Study of ARD-0403 in Testosterone Deficient Men

Hypogonadism

United States
Ardana Bioscience Ltd

Terminated

Open-Label Study of ARD-0403 in Testosterone Deficient Men (ARD-0403-010)

Hypogonadism

United States
Neurocrine Biosciences

Recruiting

A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder

Major Depressive Disorder

United States
Sanguine Biosciences

Recruiting

A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

Rare Diseases

United States
Sanguine Biosciences

Recruiting

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Heart Diseases | Stroke | Lymphoma | Multiple Sclerosis | Kidney Diseases | Diabetes | Leukemia | Age-Related Macular Degeneration | Cancer | Arthritis | Schizophrenia | Thyroid Diseases | Parkinson Disease | Hepatitis | Vasculitis | Psoriasis | Asthma | Amyloidosis | Fibromyalgia | Graves Disease | Alzheimer Disease | Celiac Disease | Cirr... and other conditions

United States
Neurocrine Biosciences

Enrolling by invitation

Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canada

Chorea, Huntington

Canada
Neurocrine Biosciences

Active, not recruiting

Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia (CAHtalyst)

Congenital Adrenal Hyperplasia

United States, Spain, Belgium, Austria, Bulgaria, Canada, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Serbia, Sweden, United Kingdom
Persephone Biosciences

Terminated

Vaccine Observation to Include All Communities for Equitable Science (VOICES)

Vaccine Adverse Reaction | Vaccine Response Impaired

United States
Pyramid Biosciences

Terminated

Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors

Solid Tumor, Adult | Desmoplastic Small Round Cell Tumor | Brain Tumor, Primary

France, United States, Spain, Hong Kong, United Kingdom, Australia, Singapore, Germany, Korea, Republic of, Italy, Denmark
KBP Biosciences

Completed

A Multiple Ascending Dose Study of KBP-7072 in Healthy Subjects

Healthy

United States
Spruce Biosciences

Active, not recruiting

A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH

Congenital Adrenal Hyperplasia

United States, Australia, Brazil, Canada, Denmark, Estonia, Germany, Ireland, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom

Clinical Trials Sponsored by SN BioScience

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations